Table 1.
Association between SLC22A3 methylation and risk of ESCC
| Group | SLC22A3 Methylation (1% increment) | ||||||
|---|---|---|---|---|---|---|---|
| OR(95% CI) | AdjOR*(95% CI) | ||||||
| High-risk region | |||||||
| Cases/Controls | 1.335(1.198-1.489) | 1.352(1.208-1.514) | |||||
| 133/115 | |||||||
| P-value | |||||||
| Likelihood ratio | 1.05E-09 | 2.06E-11 | |||||
| Wald test | 1.94E-07 | 4.88E-08 | |||||
| Score test | 2.89E-08 | 1.59E-09 | |||||
| Low-risk region | |||||||
| Cases/Controls | 1.058(0.9274-1.208) | 1.070(0.9364-1.223) | |||||
| 112/100 | |||||||
| P-value | |||||||
| Likelihood ratio | 0.397 | 0.089 | |||||
| Wald test | 0.399 | 0.098 | |||||
| Score test | 0.398 | 0.092 | |||||